Study of Biodistribution of the Modular Nanotransporters after Systemic Administration in Murine Cloudman S91 Melanoma Model

[1]  A. S. Sobolev,et al.  Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors , 2017, Drug design, development and therapy.

[2]  A. S. Sobolev,et al.  Antitumor efficacy of Auger electron emitter 111In delivered by modular nanotransporter into the nuclei of cells with folate receptor overexpression , 2017, Doklady Biochemistry and Biophysics.

[3]  A. S. Sobolev,et al.  Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters , 2017, International journal of nanomedicine.

[4]  H. Wong,et al.  A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  A. S. Sobolev,et al.  Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[6]  M. Morbidelli,et al.  Process for protein PEGylation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Greg M Thurber,et al.  A mechanistic compartmental model for total antibody uptake in tumors. , 2012, Journal of theoretical biology.

[8]  A. S. Sobolev,et al.  Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo , 2012, Doklady Biochemistry and Biophysics.

[9]  A. S. Sobolev,et al.  Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery , 2012, International journal of nanomedicine.

[10]  B. Fahy,et al.  Chemotherapy-associated hepatotoxicity: how concerned should we be? , 2010, Expert review of anticancer therapy.

[11]  A. S. Sobolev.  Modular transporters for subcellular cell-specific targeting of anti-tumor drugs. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  A. Eberle,et al.  Characterization of Receptors for α-Melanocyte-stimulating Hormone on Human Melanoma Cells , 1989 .